These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10227331)

  • 21. Genetics of allergy and asthma.
    Borish L
    Ann Allergy Asthma Immunol; 1999 May; 82(5):413-24; quiz 424-6. PubMed ID: 10353570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-5- and eosinophil-mediated inflammation: from discovery to therapy.
    Kouro T; Takatsu K
    Int Immunol; 2009 Dec; 21(12):1303-9. PubMed ID: 19819937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation analysis of interleukin-5 in an asthmatic cohort.
    Pereira E; Goldblatt J; Rye P; Sanderson C; Le Souëf P
    Hum Mutat; 1998; 11(1):51-4. PubMed ID: 9450903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The influence of dexamethasone on mRNA expression of interleukin-5, interleukin-3 and granulocyte-macrophage colony-stimulating factor receptors in eosinophils of guinea pig asthma model].
    Li Z; Wang C; Qian G
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Sep; 24(9):542-7. PubMed ID: 11758170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
    Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
    Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Involvement of interleukin-4, and -13 in the pathogenesis of allergic diseases].
    Izuhara K
    Rinsho Byori; 2001 Apr; 49(4):360-4. PubMed ID: 11391949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characterization of a receptor for interleukin-5 on pulmonary eosinophils with eosinophilic pneumonia].
    Chihara J; Nakajima S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():70-6. PubMed ID: 1306241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of IL-5 and its receptor in immune system].
    Tominaga A
    Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1177-83. PubMed ID: 1871348
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeting IL-23 in human diseases.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Targets; 2010 Jul; 14(7):759-74. PubMed ID: 20536413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-5, a therapeutic target in allergic inflammation.
    Huston DP; Huston MM; Dickason RR; Martinez-Moczygemba M
    Trans Am Clin Climatol Assoc; 2000; 111():46-59; discussion 59-60. PubMed ID: 10881331
    [No Abstract]   [Full Text] [Related]  

  • 31. Biological and molecular characteristics of interleukin-5 and its receptor.
    Karlen S; De Boer ML; Lipscombe RJ; Lutz W; Mordvinov VA; Sanderson CJ
    Int Rev Immunol; 1998; 16(3-4):227-47. PubMed ID: 9505190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases.
    Weiss E; Mamelak AJ; La Morgia S; Wang B; Feliciani C; Tulli A; Sauder DN
    J Am Acad Dermatol; 2004 May; 50(5):657-75; quiz 676-8. PubMed ID: 15097948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-5 and IL-5 receptor in health and diseases.
    Takatsu K
    Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(8):463-85. PubMed ID: 21986312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-5, eosinophilic diseases and therapeutic intervention.
    Zabeau L; Gevaert P; Bachert C; Tavernier J
    Curr Drug Targets Inflamm Allergy; 2003 Dec; 2(4):319-28. PubMed ID: 14561151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-5 and its receptor system: implications in the immune system and inflammation.
    Takatsu K; Takaki S; Hitoshi Y
    Adv Immunol; 1994; 57():145-90. PubMed ID: 7872157
    [No Abstract]   [Full Text] [Related]  

  • 36. Structure/function analysis of human interleukin 5 and its receptor.
    Tavernier J; Cornelis S; Devos R; Guisez Y; Plaetinck G; Van der Heyden J
    Agents Actions Suppl; 1995; 46():23-34. PubMed ID: 7610988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutated interleukin-5 monomers are biologically inactive.
    McKenzie AN; Ely B; Sanderson CJ
    Mol Immunol; 1991; 28(1-2):155-8. PubMed ID: 1901378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of interleukin-6 in certain age-related diseases.
    Ershler WB; Sun WH; Binkley N
    Drugs Aging; 1994 Nov; 5(5):358-65. PubMed ID: 7833589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [IL-5 AND ALLERGIC INFLAMMATION].
    Takatsu K
    Arerugi; 2018; 67(2):108-113. PubMed ID: 29553109
    [No Abstract]   [Full Text] [Related]  

  • 40. IL-5 and eosinophilia.
    Takatsu K; Nakajima H
    Curr Opin Immunol; 2008 Jun; 20(3):288-94. PubMed ID: 18511250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.